Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 449.76 Million | 705.97 Million | 564.05 Million | 471.51 Million | 515.14 Million | 654.8 Million |
| Cost of Revenue | 198 Million | 405.61 Million | 268.1 Million | 215.44 Million | 233.4 Million | 332.03 Million |
| Gross Profit | 251.76 Million | 300.36 Million | 295.95 Million | 256.07 Million | 281.74 Million | 322.76 Million |
| Operating Expenses | 239.64 Million | 251.73 Million | 220.46 Million | 201.86 Million | 224.32 Million | 215.78 Million |
| Selling, General and Administrative Expenses | 194.86 Million | 139.13 Million | 120.74 Million | 107.21 Million | 111.6 Million | 117.95 Million |
| Research and Development Expenses | 36.87 Million | 34.95 Million | 32.75 Million | 38.47 Million | 48.31 Million | 39.97 Million |
| Other Expenses | 7.9 Million | -30.73 Million | 2.08 Million | 1.25 Million | 116.83 Thousand | -178.72 Thousand |
| Cost and Expenses | 437.64 Million | 657.35 Million | 488.57 Million | 417.3 Million | 457.72 Million | 547.82 Million |
| Operating Income | 23.9 Million | 7.56 Million | 60.18 Million | -7.78 Million | 31.39 Million | 72.79 Million |
| Interest Expense | 737.02 Thousand | 1.28 Million | 2.15 Million | 2.56 Million | 3.98 Million | 6.22 Million |
| Income Tax Expense | 1.87 Million | 10.87 Million | 11.62 Million | 14.62 Million | 3.54 Million | 10.45 Million |
| Earnings before Tax | 24.53 Million | -25.16 Million | 58.8 Million | -14.79 Million | 31.51 Million | 72.61 Million |
| Net Income | 15.33 Million | -56.27 Million | 22.41 Million | -50.98 Million | 6.3 Million | 40.47 Million |
| Earnings Per Share Basic | 0.03 | -0.10 | 0.05 | -0.12 | 0.02 | 0.10 |
| Earnings Per Share Diluted | 0.03 | -0.10 | 0.05 | -0.12 | 0.02 | 0.10 |
| Weighted Average Shares Outstanding | 511.24 Million | 544.01 Million | 448.38 Million | 417.79 Million | 417.79 Million | 419.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 511.24 Million | 544.01 Million | 448.38 Million | 417.79 Million | 417.79 Million | 421.14 Million |
| Gross Margin | 0.56 | 0.43 | 0.52 | 0.54 | 0.55 | 0.49 |
| EBIT Margin | 0.19 | 0.14 | 0.26 | 0.24 | 0.20 | 0.23 |
| Profit Margin | 0.03 | -0.08 | 0.04 | -0.11 | 0.01 | 0.06 |
| EBITDA | 86.96 Million | 36.52 Million | 119.89 Million | 44.83 Million | 79.58 Million | 119.4 Million |
| Earnings Before Tax Margin | 0.05 | 0.01 | 0.11 | -0.02 | 0.06 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 93.46 Million | 91.35 Million | 91.8 Million | 449.76 Million | 118.51 Million | 113.18 Million |
| Cost of Revenue | 45.78 Million | 52.15 Million | 44.17 Million | 250.4 Million | 63.41 Million | 48.78 Million |
| Gross Profit | 47.68 Million | 39.19 Million | 47.62 Million | 199.36 Million | 55.09 Million | 64.39 Million |
| Operating Expenses | 51.53 Million | 39.6 Million | 52.23 Million | 179 Million | 58.66 Million | 55.43 Million |
| Selling, General and Administrative Expenses | 106.08 Million | 32.37 Million | 43.28 Million | - | 47.36 Million | 76.81 Million |
| Research and Development Expenses | 7.73 Million | 7.14 Million | 8.82 Million | - | 10.42 Million | 8.68 Million |
| Other Expenses | -62.28 Million | -82.63 Thousand | -129.13 Thousand | -785.12 Thousand | -881.3 Thousand | -64.23 Thousand |
| Cost and Expenses | 97.31 Million | 91.76 Million | 96.41 Million | 429.41 Million | 122.08 Million | 104.21 Million |
| Operating Income | 1.84 Million | -409.48 Thousand | -4.61 Million | 20.35 Million | -3.57 Million | 12.96 Million |
| Interest Expense | 68.49 Thousand | 79.81 Thousand | 90.96 Thousand | 653.61 Thousand | 134.24 Thousand | 131.16 Thousand |
| Income Tax Expense | 1.26 Million | -215.19 Thousand | 1.92 Million | 1.87 Million | -5.9 Million | 2.97 Million |
| Earnings before Tax | 1.86 Million | 5.31 Million | 745.1 Thousand | 24.53 Million | -11.9 Million | 12.15 Million |
| Net Income | 465.47 Thousand | 3.31 Million | -2.7 Million | 15.33 Million | -8.42 Million | 7.27 Million |
| Earnings Per Share Basic | 0.00 | 0.01 | -0.01 | - | -0.02 | 0.01 |
| Earnings Per Share Diluted | 0.00 | 0.01 | -0.01 | - | -0.02 | 0.01 |
| Weighted Average Shares Outstanding | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million | 544.01 Million |
| Gross Margin | 0.51 | 0.43 | 0.52 | 0.44 | 0.46 | 0.57 |
| EBIT Margin | 0.02 | 0.18 | -0.01 | - | 0.14 | 0.12 |
| Profit Margin | 0.00 | 0.04 | -0.03 | 0.03 | -0.07 | 0.06 |
| EBITDA | 1.92 Million | 16.76 Million | -1.08 Million | - | 16.35 Million | 13.24 Million |
| Earnings Before Tax Margin | 0.02 | -0.00 | -0.05 | 0.05 | -0.03 | 0.11 |
ACNB
3178
6793
5284
3596
1324